Skip to content

Skinvisible, Inc.: 10-Q filed 2023-08-14

What Skinvisible, Inc. reported in its quarterly report filed 2023-08-14 (fiscal Q2 2023): 28 published measures, 82 facts as tagged in accession 0001663577-23-000402.

This filing

Form
10-Q (quarterly report)
Filed
2023-08-14
Fiscal period
fiscal Q2 2023
Accession
0001663577-23-000402 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Skinvisible, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-06-30196,319USD
At 2022-12-31246,793USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-06-308,628,053USD
At 2022-12-316,887,396USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-06-30-8,431,734USD
At 2023-03-31-8,155,659USD
At 2022-12-31-6,640,603USD
At 2022-06-30-5,821,958USD
At 2022-03-31-5,630,235USD
At 2021-12-31-5,415,716USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-276,075USD91
2023-01-01 to 2023-06-30-1,791,131USD181
1999-03-06 to 2023-06-30-38,789,179USD8883
2023-01-01 to 2023-03-31-1,515,056USD90
2022-04-01 to 2022-06-30-191,723USD91
2022-01-01 to 2022-06-30-406,242USD181
2022-01-01 to 2022-03-31-214,519USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-68,496USD181
2022-01-01 to 2022-06-30123,603USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-04-01 to 2023-06-305,000USD91
2023-01-01 to 2023-06-3010,000USD181
2022-04-01 to 2022-06-30205,000USD91
2022-01-01 to 2022-06-30264,980USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-27,299USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-9,334USD181
2022-01-01 to 2022-06-30-2,005USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-06-30-38,789,179USD
At 2022-12-31-36,998,048USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-04-01 to 2023-06-304,539,843shares91
2023-01-01 to 2023-06-304,539,843shares181
2022-04-01 to 2022-06-304,539,843shares91
2022-01-01 to 2022-06-304,539,843shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-04-01 to 2023-06-304,539,843shares91
2023-01-01 to 2023-06-304,539,843shares181
2022-04-01 to 2022-06-304,539,843shares91
2022-01-01 to 2022-06-304,539,843shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-0.06USD/shares91
2023-01-01 to 2023-06-30-0.39USD/shares181
2022-04-01 to 2022-06-30-0.04USD/shares91
2022-01-01 to 2022-06-30-0.09USD/shares181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-112,823USD91
2023-01-01 to 2023-06-30-240,727USD181
2022-04-01 to 2022-06-3085,990USD91
2022-01-01 to 2022-06-306,451USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-06-3059,622USD
At 2022-12-31109,946USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-04-01 to 2023-06-30167,522USD91
2023-01-01 to 2023-06-301,551,636USD181
2022-04-01 to 2022-06-30290,945USD91
2022-01-01 to 2022-06-30580,514USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-06-302,980,174USD
At 2022-12-313,644,986USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2023-06-30136,697USD
At 2022-12-31136,847USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-04-01 to 2023-06-30117,823USD91
2023-01-01 to 2023-06-30250,727USD181
2022-04-01 to 2022-06-30119,010USD91
2022-01-01 to 2022-06-30257,021USD181

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-04-01 to 2023-06-305,000USD91
2023-01-01 to 2023-06-3010,000USD181
2022-04-01 to 2022-06-30205,000USD91
2022-01-01 to 2022-06-30263,472USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-01-01 to 2022-06-301,508USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2023-04-01 to 2023-06-30112,983USD91
2023-01-01 to 2023-06-30241,243USD181
2022-04-01 to 2022-06-30114,332USD91
2022-01-01 to 2022-06-30247,750USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-06-304,539,843shares
At 2022-12-314,539,843shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-06-303,548USD
At 2022-12-3181,378USD
At 2022-06-30160,336USD
At 2021-12-3166,037USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-06-3030,352,905USD
At 2022-12-3130,352,905USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2023-06-30-8,431,734USD
At 2022-12-31-6,640,603USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-06-307,890USD
At 2022-12-319,495USD

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-01-01 to 2023-06-309,484USD181
2020-01-01 to 2020-09-309,271USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-4,918USD181

Inspect the source

Entity
Skinvisible, Inc. / CIK 0001085277
Captured
2026-09-19T11:16:20.960Z
SEC response SHA-256
973a5bad8e2b048a60b601a0e5e1fba53bc9ca7b963661d1ad0a9561b8d208d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001085277.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))